Posted inBiologic Drugs BioTech Medicines
Big Pharma’s $600B US investment
While large pharmaceutical companies in 2025 announced a total of approximately $600 billion in multi-year commitments to U.S.-based manufacturing and R&D, just $60 billion of the potential capital expenditure projects…
